drugset / Trial / NCT01257919

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

NCT01257919

Phase 1 Completed 21 enrolled LEO Pharma Bayer · collab
RandomizedCrossoverSingle-blindTreatment

Summary

Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel. Assessment of safety after repeated skin application.

Timeline

Start
2011-01
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule Topical

Indications